Surgeon Patents New Option for Aortic Arch Repair in People with Aneurysms

The new device allows doctors to treat aortic arch disease and proximal descending thoracic disease without surgery. Image provided

Arthur Kemp was suffering. He’d had two strokes, and an aortic aneurysm threatened to wreak further havoc. It needed to be treated. During a visit to the MUSC Health Heart and Vascular Center to talk about that, he learned something that surprised him – in a good way.

“I was scared at first because I thought I had to have an operation. But I thank God that I didn’t. And when he told me that, I’m like, ‘Whew!’”

“He” was Mathew Wooster, M.D., a vascular surgeon who’d worked with colleagues to come up with a new device that they could use in cases like Kemp’s, no open surgery needed. Instead, the doctor and his team could use the minimally invasive procedure he patented. 

It’s formally called endovascular total aortic arch graft and method of placement. The other doctors on the patent are Sanford Zeigler, M.D., Adam Tanious, M.D., and Ryan Gedney, M.D.

“It came about from a patient need, quite frankly,” Wooster said. “We see a very large number of patients who have aortic arch disease or proximal descending thoracic disease. And there aren’t any true devices that are currently designed for it. Historically, it’s been an area that has only had the option of having open surgical repair.”

The disease involves the aorta, the largest artery in the body. Sometimes, part of its wall weakens due to a medical condition, genetics or trauma. Then, blood pressure can cause a bulge, or aneurysm, in that part of the wall. If the aneurysm gets too big, it can burst or tear the arterial wall. That’s what Wooster’s invention is designed to prevent. It uses what they call a graft, which is a tube, to shore up the weak part of the aorta. The design of the new system is what sets it apart.

Red tube curves to the left. It has four tubes coming off of the top of it and others on its sides. It says aorta structure.
The aortic arch carries blood to the head and the body’s upper extremities.

“Essentially, our standard devices that existed for this are a straight sort of a tube. It’s a cylinder made of plastic and metal that goes inside, and it’s sort of like a spring that opens up inside of the body and holds itself against the aortic wall,” Wooster said.

“The next step to that is what we call fenestrated devices. They’re things that have a single hole cut out in the side. And you line that hole up with the branches that go to the aortic arch. 

“And then our design is sort of a modification of that, where we actually put it distal to the branches so it’s not actually covering anything.” Distal means far from the branches of the the aorta.

“And it has three arms coming out of it. And then we eventually connect those arms up to the brain and up to your arms. So that it seals things off without ever having to obstruct the blood flow to those vessels.”

Wooster, an associate professor of Vascular Surgery at the Medical University of South Carolina, said it adds to patients’ options. Some of those options are being tested at MUSC Health. 

“We’re part of clinical trials where we do bypasses from one side of the neck to the other and then have a single hole going into the great vessels. And those early trials are good, but they do still require surgery. They require a bypass from one side to the other. Okay. And they still have that 4% to 10% stroke rate associated with them.”

Wooster said his design is a way to avoid doing a bypass, which reduces that stroke risk. “And it allows us to, what we call ‘fail forward.’ We know aneurysms are degenerative disease. We know there’s a chance they’re going to need another operation in the future. And our design makes it very easy for us to do that if they were to need another operation ever in the future.”

Wooster said they worked with the Zucker Institute for Innovation and Commercialization to patent it. The institute is a nonprofit that examines and manages inventions such as Wooster’s that were created at the Medical University of South Carolina. “This would just be some off-label thing that we do and we keep offering to patients, and it wouldn’t get out there to other doctors as a design if it weren’t for the Zucker Institute.”

Kemp is glad that design was available when he needed it. “I feel much better.”

He had some advice for other patients with aortic issues. “Don’t be scared. Yeah. Because I was very scared. And I just gave it to God. I said, ‘God, you gotta help me with this.’”

Wooster continues to see Kemp for checkups. “He’s doing great. He’s at home. He’s still going to be in close surveillance because he’s still at high risk for problems in the future. But at least for now, his aneurysm is not growing anymore. And he is home and functional and really just back to his baseline before this all started. It’s amazing. Those are the wins that we live for.”

Written by Helen Adams

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.